Compare Nokia Corp (NOK) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs Nuwellis Inc — how do they compare? Nokia Corp trades at $10.34 (market cap $56.99B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Nokia Corp is far larger — about 25904.5× Nuwellis Inc's market cap, and Nokia Corp pays a 1.61% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nokia Corp for 66 Days and Nuwellis Inc for 26 Days on average.
| NOK | NUWE | |
|---|---|---|
Market Cap | $56.99B | $2.20M |
Volume | 69,968,204 | 121,544 |
Sector | Technology | Health |
52-Week High | $16.83 | $146.65 |
52-Week Low | $5.18 | $0.68 |
Typical Hold Time | 66 Days | 26 Days |
Enterprise Value | $55.01B | -$1.52M |
Dividend Yield | 1.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nokia (NOK) trades at $10.62, down 3.19% on the day, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue for 2025 was $19.89 billion with a net income margin of 3.47%. Recent news highlights a strategic partnership with Microsoft for AI-driven network automation and sovereign satellite network development with ICEYE, positioning Nokia in high-growth infrastructure segments.
The outlook is supported by strong analyst sentiment with a consensus price target of $17.50, implying significant upside. Key opportunities include expanding AI and cloud orders, while risks involve competitive pressures and execution challenges in integrating new technologies. Cash flow volatility and a high P/E ratio of 78.9 warrant caution, but institutional buy ratings suggest confidence in long-term growth.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
